David Rabin MD, PhD is the Chief Innovation Officer, Co-Inventor & Co-Founder of Apollo Neuroscience – As a psychiatrist and translational neuroscientist, Dr. Rabin specializes in developing novel, non-invasive therapies for treatment-resistant physical and mental illnesses. His research focuses on chronic stress from the cellular and molecular level to the body as a whole. Dr. Rabin works to identify new healthcare markets, to evaluate Apollo’s real-world efficacy through clinical trials, and to guide the development of the Apollo technology.

Location

Pittsburgh, PA.

What’s your favorite vegetable?

Parsnips.

What’s your motto?

Be water, my friend.

What’s your favorite book?

In Search of Memory – Eric Kandel

What’s your favorite exercise?

Skiing/Beach Volleyball.

What’s your favorite way to center?

Deep-breathing meditation and dancing.

David’s Daily Routine:

  • 5:30-6 am high protein snack
  • 6-7 am Workout (lifting, cardio, or yoga)
  • 7-730 wind down/meditation
  • 730-8:30 am shower/breakfast
  • 8:30 am-7 pm work with 15 minute breaks every 1-2 hours
  • 7-9 pm Dinner
  • 9-10 pm wind down for bed
  • 10pm-530am sleep

What gets you out of bed every morning?

Excitement about what new things I will learn each day from my work and all of the wonderful people I work with.

What is the most important part of your daily routine?

Breaks and breaths (I consider working out and eating to be part of break time)

What is your #1 wellness habit?

Letting go.

What is the best piece of health advice you’ve ever received?

Practice makes perfect.

What is your favorite part of living a healthy lifestyle?

Feeling better. Doing better. Being at my best.

If you could give one piece of health advice to your family, what would it be and why?

If you’re going to take the time to do something, do it right the first time.

If you liked this article, you’ll also love:

David Rabin is a psychiatrist, neuroscientist,  and co-founder of Apollo Neuroscience. Check out David’s work on his website, and follow David on Facebook and Twitter.